Navigation Links
NEXUS Biosystems Completes Acquisition of REMP Sample Management Business From Tecan Group
Date:9/8/2010

POWAY, Calif., Sept. 8 /PRNewswire/ -- NEXUS Biosystems, Inc., a leading innovator and worldwide provider of automated sample management systems, today announced the completion of the acquisition of REMP AG of Switzerland, a wholly-owned subsidiary of the Tecan Group.  

NEXUS announced on July 15, 2010 that it would acquire Tecan's worldwide REMP Sample Management business.  REMP is a leading global provider of sample management systems and related sample management devices, instruments, consumables and software.  With this acquisition, NEXUS will be adding to its current operations in the United States and Germany the REMP operations in Switzerland, Germany, Japan and the United States.  REMP provides additional R&D, manufacturing, sales and customer support operations in Switzerland and direct sales and customer support in Kawasaki, Japan.

John Lillig‚ CEO of NEXUS Biosystems, commented: "Both REMP and NEXUS have been strong innovators and leaders in the growing global automated chemical and biological sample management markets.  Together, with our new REMP colleagues, we look forward to continuing to provide leading sample management solutions to our biopharmaceutical, biorepository, diagnostic, forensic, agrochemical and genomic research customers around the world.   The combined NEXUS-REMP resources will strengthen our overall capabilities with expanded first-class service and support for our worldwide customers and a growing pipeline of new product offerings for the growing global sample management community."

About NEXUS Biosystems:

NEXUS Biosystems (www.nexusbio.com) is a leading innovator and worldwide provider of enabling technologies and automated sample management systems for pharmaceutical, biotech, biorepository, agrochemical and related research institutions worldwide.  NEXUS products include the NEXUS Universal Store family of automated ambient, -20 degrees C and -80 degrees C chemical and biological sample management systems, the REMP SSS, MSS and LSS family of automated ambient and -20C chemical and biological sample management systems, devices and sample storage containers, the Aurora line of high performance microplates, the NEXUS XPeel microplate de-sealer, and the NEXUS Crystal Farm line of protein crystallization systems.  NEXUS was founded in 2005, is headquartered in Poway, CA, has subsidiaries in Oberdiessbach Switzerland, Munich Germany, and Kawasaki Japan, and distribution offices throughout the US, Europe and Asia.

www.nexusbio.com


'/>"/>
SOURCE NEXUS Biosystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. NEXUS Biosystems Acquires Tecan Groups REMP Sample Management Business
2. AACR Data Highlights InNexus Preclinical Antibody Candidate
3. InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
4. Incept BioSystems Initiates First Human Clinical Trial of its SMART Embryo Culture System for In Vitro Fertilization (IVF)
5. Abbott Completes Acquisition of Piramals Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
6. Mylan Completes Acquisition of Bioniche Pharma Sooner Than Expected
7. Salinas Valley Memorial Completes Successful Implant of Cardiac Monitor and Alert System
8. CMC Biologics Completes First Stage of Expansion with Addition of Single-Use Facility
9. Warner Chilcott Completes Amendment to Existing Senior Secured Credit Facilities and Closes Senior Notes Offering; Company Declares Special Cash Dividend of $8.50 Per Share and Updates Full-Year 2010 Financial Guidance
10. CeNeRx BioPharma Completes $13 Million Series C Financing
11. BD Completes Sales of Ophthalmic Systems Unit and Surgical Blades Product Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... BOSTON , March 27, 2017 ... pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), ... commercialization of innovative therapies based upon tetracycline chemistry, ... sarecycline for the treatment of moderate to severe ... Sarecycline is a once-daily, oral, narrow spectrum tetracycline-derived ...
(Date:3/27/2017)... 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that ... Bisaro as Impax,s President and Chief Executive Officer ... 27, 2017. Mr. Bisaro will succeed J. Kevin ... Chief Executive Officer since December of 2016. ... experience, Mr. Bisaro, 56, is an accomplished global business ...
(Date:3/27/2017)... 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), a ... liver diseases in children, today reported financial results ... December 31, 2016 and provided an update on ... to make progress during the fourth quarter of ... our non-human primate safety study, and with our lead ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... The Anaheim Hills office ... First National Capital has added 10 new sales professionals over the past 6 months ... by 15 additional new hires over the course of 2017. , “This new ...
(Date:3/27/2017)... Orange, Texas (PRWEB) , ... March 27, 2017 ... ... celebration at the GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to ... giveaways and will be an opportunity for area-residents to celebrate two great years ...
(Date:3/26/2017)... ... March 26, 2017 , ... Local physician Dr. Justin ... a prestigious award honoring the top influencers on RealSelf—the most trusted online destination ... doctors and clinics. , In 2016, more than 82 million people visited RealSelf ...
(Date:3/24/2017)... ... March 24, 2017 , ... Vighter ... the same time by providing Prehospital Trauma Life Support (PHTLS) course scholarships to ... premier prehospital trauma education developed in cooperation with the American College of Surgeons ...
(Date:3/24/2017)... ... ... The Radiology Business Management Association (RBMA) has named the nine winners ... year, are among the most prestigious in radiology marketing because a panel of radiology ... recognize achievements in both large budget (over $5,000) and small budget (under $5,000) campaigns. ...
Breaking Medicine News(10 mins):